全文获取类型
收费全文 | 112479篇 |
免费 | 4999篇 |
国内免费 | 593篇 |
专业分类
耳鼻咽喉 | 1767篇 |
儿科学 | 6403篇 |
妇产科学 | 2562篇 |
基础医学 | 9756篇 |
口腔科学 | 4080篇 |
临床医学 | 7808篇 |
内科学 | 25648篇 |
皮肤病学 | 3331篇 |
神经病学 | 7607篇 |
特种医学 | 5285篇 |
外科学 | 24220篇 |
综合类 | 2197篇 |
预防医学 | 5965篇 |
眼科学 | 2250篇 |
药学 | 4968篇 |
2篇 | |
中国医学 | 775篇 |
肿瘤学 | 3447篇 |
出版年
2023年 | 3466篇 |
2022年 | 4163篇 |
2021年 | 5718篇 |
2020年 | 4347篇 |
2019年 | 11537篇 |
2018年 | 8692篇 |
2017年 | 4261篇 |
2016年 | 1347篇 |
2015年 | 1947篇 |
2014年 | 2700篇 |
2013年 | 1365篇 |
2012年 | 841篇 |
2011年 | 4260篇 |
2010年 | 1211篇 |
2009年 | 1645篇 |
2008年 | 1713篇 |
2007年 | 1212篇 |
2006年 | 1006篇 |
2005年 | 1532篇 |
2004年 | 1570篇 |
2003年 | 1072篇 |
2002年 | 1634篇 |
2001年 | 1977篇 |
2000年 | 3057篇 |
1999年 | 3398篇 |
1998年 | 3224篇 |
1997年 | 2169篇 |
1996年 | 1454篇 |
1995年 | 1004篇 |
1994年 | 1059篇 |
1993年 | 736篇 |
1992年 | 908篇 |
1991年 | 630篇 |
1990年 | 690篇 |
1989年 | 451篇 |
1988年 | 519篇 |
1987年 | 320篇 |
1985年 | 2751篇 |
1984年 | 4063篇 |
1983年 | 2893篇 |
1982年 | 2835篇 |
1981年 | 2676篇 |
1980年 | 2365篇 |
1979年 | 2192篇 |
1978年 | 1804篇 |
1977年 | 1565篇 |
1976年 | 1691篇 |
1975年 | 1438篇 |
1974年 | 1277篇 |
1973年 | 1201篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
53.
54.
55.
《Revista espa?ola de cardiología》2019,72(12):1012-1019
Introduction and objectivesThe Spanish Society of Cardiology/Spanish Heart Foundation (SEC/FEC) annually awards grants for cardiovascular research projects. Our objective was to analyze the trend in these investments and their resulting scientific production from 2007 to 2012.MethodsA search of the publications funded by the SEC/FEC was carried out, according to the following inclusion criteria: publication in a journal indexed in MEDLINE or EMBASE, publication date after the grant, authorship by the principal investigator of the grant, and acknowledgment of SEC/FEC funding. The impact factor and subsequent citations of the articles were analyzed (Web of Science).ResultsA total of 235 grants were awarded (39/y) with an allocation of €3 854 300 (€642 383/y), 37% of them to women. In all, 122 publications resulted from 88 research projects (37%) funded by the SEC/FEC. Up to October 2017, these publications had received 2258 citations in subsequent studies in the Web of Science, with a mean of 18.5 and a median of 8 citations/study.ConclusionsDespite the economic crisis, the mean number and size of the grants awarded by the SEC/FEC increased in the period analyzed. Grants were awarded on an equal opportunity basis to men and women. The bibliometric impact of the funded projects is acceptable, although efforts should be made to improve it. 相似文献
56.
57.
《Drug metabolism and pharmacokinetics》2019,34(5):308-316
LC-MS quantification of drug metabolites is sometimes impeded by the availability of internal standards that often requires customized synthesis and/or extensive purification. Although isotopically labeled internal standards are considered ideal for LC-MS/MS based quantification, de novo synthesis using costly isotope-enriched starting materials makes it impractical for early stage of drug discovery. Therefore, quick access to these isotope-enriched compounds without chemical derivatization and purification will greatly facilitate LC-MS/MS based quantification. Herein, we report a novel 18O-labeling technique using metabolizing enzyme carboxylesterase (CES) and its potential application in metabolites quantification study. Substrates of CES typically undergo a two-step oxygen exchange with H218O in the presence of the enzyme, generating singly- and doubly-18O-labeled carboxylic acids; however, unexpected hydrolytic behavior was observed for three of the test compounds – indomethacin, piperacillin and clopidogrel. These unusual observations led to the discovery of several novel hydrolytic mechanisms. Finally, when used as internal standard for LC-MS/MS based quantification, these in situ labeled compounds generated accurate quantitation comparable to the conventional standard curve method. The preliminary results suggest that this method has potential to eliminate laborious chemical synthesis of isotope-labeled internal standards for carboxylic acid-containing compounds, and can be developed to facilitate quantitative analysis in early-stage drug discovery. 相似文献
58.
《Nutrition, metabolism, and cardiovascular diseases : NMCD》2022,32(12):2883-2889
Background and aimsCoronary artery disease (CAD) is the principal cause of death in individuals with non-alcoholic fatty liver disease (NAFLD). The aim of this study was to use genetic epidemiology to study the association between de novo lipogenesis (DNL), one of the major pathways leading to NAFLD, and CAD risk.Methods and resultsDNL susceptibility genes were used as instruments and selected using three approaches: 1) genes that are associated with both high serum triglycerides and low sex hormone-binding globulin, both downstream consequences of DNL (unbiased approach), 2) genes that have a known role in DNL (biased approach), and 3) genes that have been associated with serum fatty acids, used as a proxy of DNL. Gene-CAD effect estimates were retrieved from the meta-analysis of CARDIoGRAM and the UK Biobank (~76014 cases and ~264785 controls). Effect estimates were clustered using a fixed-effects meta-analysis. Twenty-two DNL susceptibility genes were identified by the unbiased approach, nine genes by the biased approach and seven genes were associated with plasma fatty acids. Clustering of genes selected in the unbiased and biased approach showed a statistically significant association with CAD (OR:1.016, 95%CI:1.012; 1.020 and OR:1.013, 95%CI:1.007; 1.020, respectively), while clustering of fatty acid genes did not (OR:1.004, 95%CI:0.996–1.011). Subsequent exclusion of potential influential outliers did reveal a statistically significant association (OR:1.009, 95%CI:1.000; 1.018).ConclusionsDNL susceptibility genes are associated with an increased risk of CAD. These findings suggest that DNL may be involved in the pathogenesis of CAD and favor further development of strategies that target NAFLD through DNL. 相似文献
59.
60.
《Journal of vascular and interventional radiology : JVIR》2020,31(7):1069-1073
This report describes a technique for measuring lung shunt fraction (LSF) twice in a single session during planning arteriography for radioembolization using low and standard dose technetium-99m macroaggregated albumin (99mTc-MAA). A patient with a 16.0 cm hepatocellular carcinoma and LSF of 70% was treated with lenvatinib for 4 weeks. Planning arteriography with administration of 0.5 millicuries of 99mTc-MAA was then performed. Arterial access was maintained while the LSF was calculated, which was persistently elevated at 54%. Embolization of arteriovenous shunts was performed during the same session and 5.0 millicuries of 99mTc-MAA were administered. The repeat LSF was 29%. Successful radioembolization was subsequently performed. 相似文献